Basics Regencell Bioscience Holdings Limited IPO Date: July 16, 2021 Sector: Healthcare Industry: Drug Manufacturers Market Cap: $8.39B Activated in VL: True Average Daily Range Avg Daily Range: $3.19 | 6.58% Avg Daily Range (30 D): $0.62 | 3.85% Avg Daily Range (90 D): $1.75 | 7.10% Institutional Daily Volume Avg Daily Volume: .15M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .74M Trade Size Avg Trade Size (Sh.): 57 Avg Trade Size (Sh.) (30 D): 67 Avg Trade Size (Sh.) (90 D): 54 Institutional Trades Total Inst.Trades: 51 Avg Inst. Trade: $.97M Avg Inst. Trade (30 D): $.78M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $.92M Avg Closing Trade (30 D): $.52M Avg Closing Trade (90 D): $1.04M Avg Closing Volume: 212.12K     News Jul 24, 2024 @ 9:27 AM Why Enphase Energy Shares Are Trading Higher; Here... Source: Avi Kapoor Jun 28, 2023 @ 5:04 PM Why Eton Pharmaceuticals Shares Are Trading Lower ... Source: Lisa Levin Jun 5, 2023 @ 5:09 PM Why Amedisys Shares Are Trading Higher By 14%? Her... Source: Lisa Levin Nov 11, 2022 @ 4:12 PM Flowers Foods, EverCommerce, And Some Other Big St... Source: Lisa Levin Sep 23, 2022 @ 4:16 PM Why Shares Of Oil & Gas Companies Are Trading Lowe... Source: Lisa Levin Financials   TTM Q4 2017 FY 2017 Basic EPS $.72 $.19 $.72 Diluted EPS $.72 $.19 $.72 Revenue $ 3.16B $ 861.6M $ 3.16B Gross Profit $ $ $ Net Income / Loss $ 112.3M $ 28.9M $ 112.3M Operating Income / Loss $ 271.7M $ 90.7M $ 271.7M Cost of Revenue $ $ $ Net Cash Flow $ -17.7M $ 39.3M $ -17.7M PE Ratio 22.21     Splits Jun 16, 2025:   38:1